Literature DB >> 3571585

Bolus contrast medium enhancement for distinguishing pleural from parenchymal lung disease: CT features.

E L Bressler, I R Francis, G M Glazer, B H Gross.   

Abstract

Various morphologic criteria have been proposed to distinguish pleural from pulmonary parenchymal processes using CT. Although these criteria are helpful in most instances, they are not infallible. In a retrospective review of chest CT over a 1 1/2 year period, previously described signs were not sufficient to distinguish pleural from parenchymal disease in five patients who underwent routine contrast-enhanced CT. This was true in cases of large, localized areas of air-space disease and in cases of combined pleural and parenchymal disease. In these patients bolus intravenous contrast medium administration at the plane of major abnormality proved extremely useful for diagnosis by directly demonstrating pulmonary blood vessels and/or contrast enhancement in parenchymal processes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571585     DOI: 10.1097/00004728-198705000-00013

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

1.  A PERSISTENT TRANSPLEURAL FISTULOUS COMMUNICATION BETWEEN LUNG AND CHEST WALL.

Authors:  A K Rajput; Vasu Vardhan; K E Rajan; S C Tewari
Journal:  Med J Armed Forces India       Date:  2017-06-10

2.  Management of pleural effusion, empyema, and lung abscess.

Authors:  Hyeon Yu
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 3.  Diagnostic tests in pleural effusion--an update.

Authors:  N Berkman; M R Kramer
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

4.  Intrapleural administration of streptokinase in complicated purulent pleural effusion: a CT-guided strategy.

Authors:  E Roupie; K Bouabdallah; C Delclaux; C Brun-Buisson; F Lemaire; N Vasile; L Brochard
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.